An article on considerations for plan sponsors ahead of the rollout of a new generation of obesity drugs was the most-read article on BenefitsCanada.com. Here are the top five human resources, benefits, pension and investment stories of the past week: 1. What plan sponsors should know ahead of rollout of new obesity drugs in Canada 2. What’s […]
A new generation of glucagon-like peptide-1 drugs approved for the treatment of obesity will soon be available in Canada, presenting an opportunity for plan sponsors to meet members’ health and wellness needs. It’s important for employers to consider meeting with their insurer now to find out how the rollout of these drugs will affect their […]
While medications for three interconnected chronic conditions — cardiovascular disease, diabetes and obesity — represent a growing proportion of employers’ drug spend, there’s plenty that can be done to help employees’ slow the progression of these conditions while managing drug plan costs, said Joyce Wong, director of clinical services at Express Scripts Canada, during Benefits […]
It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing common hurdles within their own drug plans, said John Adams, chair of the board of directors for patient advocacy group Best Medicines Coalition, during a session at Benefits Canada’s 2023 Face […]
A story about the B.C. Lottery Corp.’s new inclusive holiday program was the most-read story on BenefitsCanada.com this week. Here are the top five human resources, benefits, pension and investment stories of the past week. 1. BCLC allowing employees to swap statutory holidays for personal, cultural days of significance 2. My Take: Obesity should be treated like […]
As someone who has become increasingly overweight in the last few years, every time I read or write about obesity being referred to as a ‘lifestyle condition’ it makes me physically cringe. Yes, some poor diet choices have contributed to my current physical condition, but it’s much more complex than that. And I know others […]
Obesity has long been misunderstood and stigmatized as a lifestyle condition instead of a complex disease, said Rami Halabi, a medical science liaison with Novo Nordisk, during a webinar hosted by Benefits Canada and sponsored by Novo Nordisk in November. The condition isn’t just a measure of size, but a progressive, relapsing chronic disease characterized […]
More than half (58 per cent) of global insurers say they anticipate higher health benefits costs over the next three years, with the average global cost trend projected to increase by 9.9 per cent in 2024, according to a new survey by WTW. The survey, which polled more than 260 insurers representing 66 countries, found […]
The average per-employee cost of U.S. employer-sponsored health benefits has risen by 5.2 per cent in 2023 to reach US$15,797, according to a new survey by Mercer. The survey, which polled more than 1,900 U.S. employers, found cost increases were highest for employers with 50 to 499 employees (7.8 per cent on average) and these […]
While three-quarters (76 per cent) of U.S. employers say they provide coverage of glucagon-like peptide-1 drugs for diabetes management, about a quarter (27 per cent) provide coverage of these drugs for weight loss, according to a new survey by the International Foundation of Employee Benefit Plans. The survey, which polled more than 200 U.S. benefits […]